Ascendis Pharma A (ASND) Interest Expenses (2016 - 2025)
Historic Interest Expenses for Ascendis Pharma A (ASND) over the last 12 years, with Q3 2025 value amounting to -$78.2 million.
- Ascendis Pharma A's Interest Expenses fell 18097.74% to -$78.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 9572.31%. This contributed to the annual value of $108.3 million for FY2024, which is 12834.86% up from last year.
- According to the latest figures from Q3 2025, Ascendis Pharma A's Interest Expenses is -$78.2 million, which was down 18097.74% from $37.4 million recorded in Q2 2025.
- Ascendis Pharma A's Interest Expenses' 5-year high stood at $83.8 million during Q1 2024, with a 5-year trough of -$78.2 million in Q3 2025.
- In the last 5 years, Ascendis Pharma A's Interest Expenses had a median value of $10.2 million in 2023 and averaged $14.4 million.
- In the last 5 years, Ascendis Pharma A's Interest Expenses soared by 2210937.59% in 2023 and then plummeted by 20429.14% in 2024.
- Over the past 5 years, Ascendis Pharma A's Interest Expenses (Quarter) stood at -$447292.7 in 2021, then grew by 29.75% to -$314236.2 in 2022, then skyrocketed by 22109.38% to $69.2 million in 2023, then tumbled by 100.02% to -$13891.7 in 2024, then tumbled by 562928.56% to -$78.2 million in 2025.
- Its Interest Expenses was -$78.2 million in Q3 2025, compared to $37.4 million in Q2 2025 and $47.1 million in Q1 2025.